234 related articles for article (PubMed ID: 12205558)
1. Pancreaticoduodenectomy for islet cell tumors of the head of the pancreas: long-term survival analysis.
Sarmiento JM; Farnell MB; Que FG; Nagorney DM
World J Surg; 2002 Oct; 26(10):1267-71. PubMed ID: 12205558
[TBL] [Abstract][Full Text] [Related]
2. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
[TBL] [Abstract][Full Text] [Related]
3. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
4. Pancreaticoduodenectomy for selected pancreatic endocrine tumors.
Udelsman R; Yeo CJ; Hruban RH; Pitt HA; Niederhuber JE; Coleman J; Cameron JL
Surg Gynecol Obstet; 1993 Sep; 177(3):269-78. PubMed ID: 8102815
[TBL] [Abstract][Full Text] [Related]
5. Resection of pancreatic neuroendocrine tumors: results of 70 cases.
Kazanjian KK; Reber HA; Hines OJ
Arch Surg; 2006 Aug; 141(8):765-9; discussion 769-70. PubMed ID: 16924083
[TBL] [Abstract][Full Text] [Related]
6. [Management of nonfunctioning islet cell tumors of the pancreas].
Liang H; Wang XN; Wang BG; Pan Y; Ding XW; Hao XS
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):457-60. PubMed ID: 17974283
[TBL] [Abstract][Full Text] [Related]
7. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival.
Reddy S; Wolfgang CL; Cameron JL; Eckhauser F; Choti MA; Schulick RD; Edil BH; Pawlik TM
Ann Surg; 2009 Aug; 250(2):282-7. PubMed ID: 19638918
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment of nonfunctioning islet cell tumor: report of 41 cases.
Guo KJ; Liao HH; Tian YL; Guo RX; He SG; Shen K
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):469-72. PubMed ID: 15313691
[TBL] [Abstract][Full Text] [Related]
9. Nonfunctioning islet cell tumors of the pancreas: a difficult diagnosis but one worth the effort.
Madura JA; Cummings OW; Wiebke EA; Broadie TA; Goulet RL; Howard TJ
Am Surg; 1997 Jul; 63(7):573-7; discussion 577-8. PubMed ID: 9202529
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.
Sarmiento JM; Heywood G; Rubin J; Ilstrup DM; Nagorney DM; Que FG
J Am Coll Surg; 2003 Jul; 197(1):29-37. PubMed ID: 12831921
[TBL] [Abstract][Full Text] [Related]
12. Survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas.
Benassai G; Mastrorilli M; Quarto G; Cappiello A; Giani U; Mosella G
Chir Ital; 2000; 52(3):263-70. PubMed ID: 10932371
[TBL] [Abstract][Full Text] [Related]
13. Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care.
Smoot RL; Zhang L; Sebo TJ; Que FG
J Am Coll Surg; 2008 Sep; 207(3):368-70. PubMed ID: 18722942
[TBL] [Abstract][Full Text] [Related]
14. Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study.
Gullo L; Migliori M; Falconi M; Pederzoli P; Bettini R; Casadei R; Delle Fave G; Corleto VD; Ceccarelli C; Santini D; Tomassetti P
Am J Gastroenterol; 2003 Nov; 98(11):2435-9. PubMed ID: 14638345
[TBL] [Abstract][Full Text] [Related]
15. Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable?
Teh SH; Deveney C; Sheppard BC
Am J Surg; 2007 May; 193(5):610-3; discussion 613. PubMed ID: 17434366
[TBL] [Abstract][Full Text] [Related]
16. Outcome of pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for adenocarcinoma of the head of the pancreas.
Yang YM; Wan YL; Tian XD; Zhuang Y; Huang YT
Chin Med J (Engl); 2005 Nov; 118(22):1863-9. PubMed ID: 16313840
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic head resection with segmental duodenectomy: safety and long-term results.
Nakao A; Fernández-Cruz L
Ann Surg; 2007 Dec; 246(6):923-8; discussion 929-31. PubMed ID: 18043093
[TBL] [Abstract][Full Text] [Related]
18. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma.
Farnell MB; Pearson RK; Sarr MG; DiMagno EP; Burgart LJ; Dahl TR; Foster N; Sargent DJ;
Surgery; 2005 Oct; 138(4):618-28; discussion 628-30. PubMed ID: 16269290
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas.
Millikan KW; Deziel DJ; Silverstein JC; Kanjo TM; Christein JD; Doolas A; Prinz RA
Am Surg; 1999 Jul; 65(7):618-23; discussion 623-4. PubMed ID: 10399969
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma of the head of the pancreas.
Onoue S; Katoh T; Chigira H; Shibata Y; Matsuo K; Suzuki M
Hepatogastroenterology; 2002; 49(44):549-52. PubMed ID: 11995493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
